How AI is Changing the Medical Field

It’s been years since AI started changing the medical field, and now it’s a major part of how doctors are diagnosing and treating diseases. AI can even predict potential issues before they happen. This means that patients and their families can catch diseases early and prevent them from spreading. How AI is Changing the Medical …

Emerging technologies and the future of cardiovascular diseases management

Cardiovascular diseases (CVDs) are the first cause of death worldwide. An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Over three-quarters of CVD deaths take place in low- and middle-income countries. Out of the 17 million premature …

The World of Wearable Healthcare Technology

Wearable technology used in healthcare includes electronic devices worn by consumers, such as smartwatches and smart rings, which collect users’ personal health and exercise data. The devices can actually send a user’s health information to a healthcare professional in real time. The demand for wearables in healthcare is expected to increase significantly over the next …

The Heart of The Matter: Technology In The Future of Cardiology

Sound, rhythm, rate, structure, function – countless features of the heart are measured to keep it healthy for as long as possible. Recently, an army of digital health technologies joined the forces of traditional preventive tools in cardiology to counter stroke, heart attack, heart failure or any other cardiovascular risks. In the future, minuscule sensors, …

Researchers develop AI models to predict a person’s 10-year risk of stroke.

Around 15 million people across the globe suffer from a heart stroke every year, which accounts for about 5 million permanently disabled and nearly 5 million deaths worldwide. The severity of a heart attack mainly depends on the kind of prompt treatment the patient receives once the symptoms start developing. Heart attack and stroke risk …

Lecanemab: Why a new Alzheimer’s drug has attracted praise and some concern

With a considerable increase in Alzheimer’s cases worldwide over the years, the medical community desperately needs effective treatment now more than ever before. In September this year, pharmaceutical companies Biogen and Eisai published encouraging results from the clinical trials of a new drug called Lecanemab for Alzheimer’s patients. Lecanemab is a monoclonal antibody treatment that …

Pharma Supply Chain & Security World 2023

Infomed Coverage is an official Media Partner with Pharma Supply Chain & Security World starting from March 28th 2023. Event Details: · Date/s of the event: 28 – 29 March 2023 · Location: London, United Kingdom The Annual Pharma Supply Chain & Security World Summit is back in London for the 5th time, and this time with more focus …

US Midterm Elections and Drug Policy

The recent US Midterm elections were highly speculated about, and US citizens watched closely to see how it turned out. In anticipation of a red wave, the Big Pharma companies had a lot riding on these midterms. With the Inflation Reduction Act and the Biden government’s signature drug policy, the US pharmaceutical companies were looking …

The Growing Popularity of Telemedicine

After the first few cases of the COVID-19 pandemic were reported, many people quickly turned to telehealth as a means of receiving and giving medical treatment without exposing themselves to the virus. Telehealth use for doctor’s appointments and other outpatient services increased by 80% between February and August 2022. Post-pandemic telehealth As a result of …

Repotrectinib Shows Promise in Clinical Trials

Cancer is a deadly disorder that has little to no cure at all. Even after undergoing multiple surgeries and chemotherapies, people still succumb to the pain of cancer. But what if we told you those days are about to be gone? Science is on its way to making another breakthrough in its journey to fight …